Wave 7 · ClearPath-Ready Specialties
Beyond our active Waves 1–6 fit list, these three specialty verticals carry the sustained weekly prior-authorization volume that nurse-led routing was built for. Strong payer documentation, recurring renewals, and measurable revenue at risk.
Specialty Fit
Each carries sustained weekly prior-authorization volume. Each maps cleanly onto nurse-led clinical routing, payer-specific documentation, and measurable revenue recovery.
PA volume: ~35–45 auths/wk per provider; EEG, MRI brain, infusion therapy renewals drive volume
Why it's ready: High-complexity diagnostic sequencing (EEG → MRI → infusion) and recurring biologic renewals build predictable PA volume. Payer documentation demands clinical precision — exactly where nurse-led routing wins.
PA volume: ~25–35 auths/wk per provider; biologic step therapy + phototherapy cycles
Why it's ready: Biologic step-therapy requirements and phototherapy cycle reauthorizations generate steady weekly auth flow. Clear payer-specific criteria give our team a tight feedback loop to push approvals through.
PA volume: ~30–40 auths/wk per provider; infusion biologics, endoscopic procedures, hepatitis C therapy
Why it's ready: Infusion biologics (IBD) and HCV therapy regimens drive multi-stage authorizations with renewal cycles. Endoscopic procedure codes pull heavy pre-auth scrutiny — both well-suited to clinical routing.